HWHongmei Wang

Hongmei Wang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Hongmei Wang has a total of 44 co-authors. Here are the top co-authors by number of shared publications:

  • Zhuoya Maimaitiwusiman

    Second Department of Comprehensive Internal Medicine, People’s Hospital of Xinjiang Uygur Autonomous Region, Urumqi, China

    11 shared publications
  • Saiyare Xuekelati

    Second Department of Comprehensive Internal Medicine, People’s Hospital of Xinjiang Uygur Autonomous Region, Urumqi, China

    9 shared publications
  • Hong Xiang

    The Second Department of Comprehensive, Internal Medicine of People’s Hospital of the Xinjiang Uygur Autonomous Region, Urumqi, China

    6 shared publications
  • Xue Bai

    Second Department of Comprehensive Internal Medicine, People’s Hospital of Xinjiang Uygur Autonomous Region, Urumqi, China

    6 shared publications
  • Buluhan Halan

    Second Department of Comprehensive Internal Medicine, People’s Hospital of Xinjiang Uygur Autonomous Region, Urumqi, China

    4 shared publications
  • Ling Zhou

    Institute of Hypertension of the People′s Hospital of Xinjiang Uyger Autonomous Region, Center of Diagnosis, Treatment and Research of Hypertension, Xinjiang, 91, Tianchi Road, Urumqi, Xinjiang, China

    4 shared publications

Latest Publications

  • A multimodal model for clinically defined MCI integrating plasma biomarkers and brain microstructural features: a dual-cohort external validation study

    by Jiayu Ke, Saiyare Xuekelati, Zhuoya Maimaitiwusiman, Buluhan Halan, Qihong Xu, Shuke Guo, Lei Xu, Hongmei Wang

  • Open Access

    Targeting TWEAK to enhance mitochondrial biogenesis and attenuate age-related muscle mass loss

    by Zhuoya Maimaitiwusiman, Saiyare Xuekelati, Anyan Wang, Nadila Airiken, Yanbin Xu, Shuke Guo, Yining Yang, Hongmei Wang

    Mitochondrial dysfunction is an important cause of sarcopenia, and TWEAK/Fn14, as one of the major muscle wasting cytokines, its role in the development of sarcopenia by regulating mitochondrial biogenesis remains unclear. Expression of TWEAK in old and young mice was both detected. TWEAK was silenced in C2C12 myocytes using lentiviral vectors. Immunofluorescence, western blot, real-time polymerase chain reaction (RT-PCR), and ELISA were enrolled to analyze the effects of TWEAK on myotube size, mitochondrial content, mitochondrial ROS, and inflammatory factors. Additionally, aged mice received two injections of AAV9 vectors at 15 and 17 months of age. Upon reaching 18 months of age, the effects of TWEAK knockdown on grip strength, muscle mass, and gastrocnemius muscle indices were evaluated. TWEAK/Fn14 expression was significantly increased in old mice ( p < 0.001). Compared with young controls, old mice exhibited a significant decrease in grip strength ( p < 0.001) and a significant increase in lean mass ( p < 0.05), whereas no significant difference was observed in fat content. In DEX-treated C2C12 myotubes, TWEAK knockdown significantly increased myotube diameter, enhanced ATP content and mitochondrial quantity, upregulated protein expression of SIRT1, PGC-1α, and p-AMPK, and inhibited mitochondrial ROS, Ca 2+ levels, p-p38 expression, and the secretion of inflammatory cytokines (TNF-α, IL-1β, IL-6, and iNOS). In aged mice, TWEAK knockdown did not significantly alter forelimb grip strength or lean mass, but significantly increased fat mass ( p < 0.05). Mechanistically, TWEAK knockdown promoted AMPK signaling, inhibited p38 MAPK activation, enhanced mitochondrial biogenesis, and reduced serum levels of IL-1β, IL-6, and iNOS ( p < 0.05), whereas serum TNF-α levels showed no significant difference. TWEAK knockdown attenuates age-related skeletal muscle mass loss and improves mitochondrial biogenesis in skeletal muscle, accompanied by modulated inflammatory factor release and altered AMPK-p38 MAPK signaling activity. However, no significant improvement in forelimb grip strength was observed in the in vivo experiment. These findings indicate that TWEAK suppression may represent a promising strategy for preserving muscle mass and metabolic homeostasis during aging, though its capacity to fully restore functional capacity requires further investigation.

  • Open Access

    Hypertension and altitude in community-dwelling older adults: an epidemiological study in northwest China

    by Zhuoya Maimaitiwusiman, Saiyare Xuekelati, Aishanjiang Wumaier, Xue Bai, Liya Ma, Yangjing Li, Alifure Aerken, Yining Yang, Hongmei Wang

    Objectives Hypertension is a major risk factor for cardiovascular and cerebrovascular diseases, and a relationship between altitude and hypertension has been demonstrated. To better characterise this relationship, this study investigated the prevalence of hypertension and its association with altitude in community-dwelling older adults living at different altitudes in Xinjiang, northwest China. Design A cross-sectional study. Setting Xinjiang, China. Participants 50 778 community-dwelling older adults residing at varying altitudes across Xinjiang. Measures A multistage stratified sampling method was used to conduct an epidemiological survey from January 2019 to December 2019 among 50 778 community-dwelling older adults aged ≥60 years who were long-term residents of Kashgar (1289 m), Hami (738 m) and Turpan (35 m), Xinjiang. Logistic regression analysis was conducted to evaluate the association between altitude and hypertension risk. Results Mean systolic blood pressure (SBP) and diastolic blood pressure (DBP) showed significant variations (both p<0.001) across Kashgar, Hami and Turpan at different altitudes: Kashgar (SBP: 133.15±19.644 mm Hg, DBP: 76.6±11.363 mm Hg), Hami (SBP: 136.68±19.617 mm Hg, DBP: 77.25±11.808 mm Hg) and Turpan (SBP: 135.44±21.101 mm Hg, DBP: 74.87±12.785 mm Hg). Statistically significant differences in the distributions of both SBP and DBP were observed across different altitudes for both males and females (all p<0.001). The differences in the distributions of SBP and DBP at different altitudes were statistically significant in all age groups, except for ≥90 years (all p<0.001). Moreover, the differences in SBP and DBP in older individuals living at the three altitudes were statistically significant (all p<0.001) regardless of smoking status, alcohol consumption, diabetes, education level or body mass index. The hypertension prevalence rates were 40.5%, 49.5% and 54.5% in Kashgar, Hami and Turpan, respectively (p<0.001). After adjustment for sex, age group, education level, smoking, alcohol consumption, BMI, diabetes, HR, SCr, blood urea nitrogen and dyslipidaemia, the risk of hypertension was increased in Hami (OR = 1.55, 95% CI 1.45 to 1.66, p<0.001) and Turpan (OR=1.80, 95% CI 1.71 to 1.88, p1500 m) or regions with distinct ethnic, genetic or healthcare backgrounds. Furthermore, it should be emphasised that this association likely reflects altitude-related environmental factors rather than direct physiological effects of hypoxia. Additional studies are warranted to further elucidate these complex relationships.

  • Open Access

    Inhibition of TWEAK/Fn14 Ameliorates Sarcopenic Obesity by Restoring Mitochondrial Biogenesis via the AMPK/SIRT1/PGC-1α Axis

    by Saiyare Xuekelati, Zhuoya Maimaitiwusiman, Yanying Guo, Shuke Guo, Qihong Xu, Jiayu Ke, Lei Xu, Yining Yang, Hongmei Wang

    Purpose: Sarcopenic obesity (SO) represents a critical geriatric syndrome where muscle atrophy and obesity synergistically exacerbate metabolic dysfunction. While the TWEAK/Fn14 pathway is a known regulator of muscle wasting, its specific role and therapeutic potential in the pathogenesis of SO remain unclear. Methods: To mimic the lipid-rich microenvironment of SO, we utilized a “PrePA-Diff” in vitro model where C2C12 myoblasts were exposed to palmitic acid prior to differentiation. In vivo, SO was established by feeding aged (18-month-old) male C57BL/6 mice a high-fat diet (HFD) for 12 weeks. Subsequently, intramuscular injection of Adeno-associated virus (AAV)-shRNA was employed to specifically inhibit TWEAK expression in skeletal muscle. Mitochondrial function, inflammatory profiles, and signaling pathways were assessed using qPCR, Western blotting, ELISA, and functional assays. Results: Our results demonstrate that TWEAK inhibition effectively reverses the SO phenotype, characterized by improved grip strength, reduced adiposity, and lowered systemic inflammation and lipid levels. At the cellular level, TWEAK silencing rescued mitochondrial bioenergetics, indicated by enhanced ATP production and suppressed reactive oxygen species (ROS) generation and calcium influx. Molecularly, these protective effects were accompanied by the downregulation of p38 MAPK phosphorylation and the reactivation of the AMPK/SIRT1/PGC-1α signaling axis, a key driver of mitochondrial biogenesis. Conclusion: Our study identifies the TWEAK/Fn14 axis as a pivotal driver of SO pathology. We conclude that inhibiting TWEAK ameliorates sarcopenic obesity by restoring mitochondrial homeostasis via AMPK/SIRT1/PGC-1α signaling, highlighting TWEAK/Fn14 as a novel therapeutic target for age-related musculoskeletal and metabolic decline.


  • Open Access

    Causal Implication of CD52-Driven Immune Dysregulation in Sarcopenic Obesity: Integrating Mendelian Randomization and Multiomics Profiling

    by Saiyare Xuekelati, Yilihamu Abulitifu, Zhuoya Maimaitiwusiman, Lei Xu, Shuke Guo, Qihong Xu, Jiayu Ke, Hongmei Wang

    Purpose: Sarcopenic obesity patients are likely to develop exacerbated metabolic dysfunction, while the mechanism linking sarcopenia and obesity is still unclear. This study aims to explore hub genes and immune-metabolic dysregulation related to the molecular pathogenesis of sarcopenia and obesity. Methods: We used a public Gene Expression Omnibus (GEO) dataset to identify hub genes associated with sarcopenia and obesity. Weighted gene co-expression network analysis (WGCNA), protein-protein interaction (PPI), differentially expressed gene (DEG) analysis, GO/KEGG functional enrichment analyses and immune cell infiltration analysis were conducted to identify hub genes. Subsequently, these hub genes underwent multi-level validation. Results: Integrated bioinformatics analysis identified 16 shared hub genes linked to the sarcopenia–obesity nexus. These genes were mainly enriched in immune-related pathways, as supported by immune infiltration profiling. External validation in independent cohorts confirmed CD52 as a common and central gene in both sarcopenia and obesity datasets, showing significant associations with immune cell characteristics. Mendelian randomization analysis indicated potential causal links between genetically predicted CD52 levels and reduced hand grip strength as well as increased body mass index, and these results were further supported by PCR assays in clinical samples. Conclusion: The integrative analysis indicates that CD52 may function as a novel immunometabolic mediator in SO pathogenesis, underscoring its potential as a candidate biomarker for further study.


  • Open Access

    RANK hypomethylation is associated with primary osteoporosis in elderly men in Xinjiang: a case-control study

    by Zhuoya Maimaitiwusiman, Junjing Shang, Hong Xiang, Xue Bai, Buluhan Halan, Hongmei Wang

    Background: RANK is a candidate gene for osteoporosis based on both functional and genetic mechanisms. This study investigated the association between RANK methylation and osteoporosis among community-dwelling elderly people in Xinjiang, China. Methods: This case-control study was based on an epidemiological investigation. Initially, methylated cytosine-rich cytosine phosphate-guanine sites (CpGs) were identified within the RANK promoter region using a screening cohort. Subsequently, selected CpGs were detected via bisulfite sequencing in the primary cohort comprising 90 elderly men (47 with osteoporosis and 43 without). Finally, the correlations between osteoporosis and the methylation rates of the identified CpGs were assessed. Results: Age and prevalence of diabetes differed significantly between individuals with and without osteoporosis ( P = 0.025 and P = 0.005, respectively), while other factors showed no statistically significant differences between the case and control groups ( P > 0.05). The RANK methylation rate was significantly higher in the control group than in the osteoporosis group ( P < 0.001). Furthermore, after covariance analysis to adjust for age, smoking, drinking, and diabetes, a significantly higher RANK methylation rate was observed in control individuals versus those with osteoporosis among elderly men from Xinjiang ( P = 0.001). Multivariate logistic regression analysis, adjusted for confounding factors (age, smoking, alcohol consumption, and diabetes), further demonstrated that RANK hypomethylation was significantly associated with osteoporosis (odds ratio = 0.310, 95% confidence interval: 0.886–0.976). Conclusions: RANK hypomethylation shows a significant association with osteoporosis in elderly male residents in Xinjiang communities. These results support that RANK hypomethylation may play a role in the pathogenesis of osteoporosis.

  • Open Access

    Handgrip strength: A simple and effective tool to recognize decreased intrinsic capacity in Chinese older adults

    by Saiyare Xuekelati, Zhuoya Maimaitiwusiman, Hong Xiang, Aishanjiang Wumaer, Xue Bai, Hongmei Wang


  • Open Access

    Ethnic and geographic variations in multiple chronic conditions among community-dwelling older people in Xinjiang: a cross-sectional study

    by Zhuoya Maimaitiwusiman, Aishanjiang Wumaier, Wenwen Xiao, Saiyare Xuekelati, Buluhan Halan, Hong Xiang, Hongmei Wang

    Background: Multiple chronic conditions (MCC) refer to the presence of two or more chronic diseases. The incidence of MCC is higher in older people, and increases with age. Studies have shown an association between MCC and increased adverse outcome, as well as the higher mortality, decline of physical function, and poor quality of life in older populations. Herein, for the first time we provide the data of ethnic and geographic variations in the prevalence of MCC among community-dwelling older people in Xinjiang, China. Methods: A multilevel random sampling method was employed to perform an epidemiological survey in community-dwelling older adults in southern, northern, and eastern Xinjiang between January 2019 to December 2019. In total, 87,000 participants volunteered, with a response rate of 96.67%; 490 participants with incomplete data were excluded and data from 86,510 participants were analyzed. Results: Our analysis demonstrated that hypertension (51.5%), obesity (27.0%), diabetes (16.9%), heart disease (8.2%), and anxiety/depression (4.5%) were the five main chronic diseases in Xinjiang. The prevalence of MCC in the population surveyed was 33.4% (95%CI, 33.1–33.7). The prevalence in females was 36.6% (95%CI, 36.1–37), which was higher than that in male (30%,95%CI, 29.5–30.4). The prevalence of MCC in older people aged 60–69, 70–79, 80–89, and ≥ 90 years was 32.7% (95%CI, 32.2–33.3), 34.3% (95%CI, 33.9–34.7), 32.5% (95% CI, 31.7–33.3), and 25.9% (95% CI, 23.5–28.3) respectively. As far as the ethnic group was concerned, the prevalence of MCC in Uygur, Han, Kazak, Hui, and Mongolian was 31.3% (95%CI, 30.9–31.7), 34.4% (95%CI, 33.9–35), 40.4% (95%CI, 39.1–41.8), 40.8% (95%CI, 38.9–42.7), 44.4% (95%CI, 38.1–50.6), respectively. The prevalence of MCC was 32.8% (95%CI, 32.1–33.5), 31.7% (95%CI, 31.2–32.1), 36.0% (95%CI, 35.3–36.7) and 39.2% (95%CI, 38.1–40.3) among uneducated, educated for 1–6, 7–9, and more than 10 years. After adjusting for age, sex, smoking, alcohol consumption, and education by level, the binary logistic analysis showed that, compared with eastern Xinjiang, the risk of MCC in the southern area was increased (odds ratio [OR], 1.418; 95% confidence interval [CI], 1.367–1.471), and it was relatively higher in northern Xinjiang (OR, 2.021; 95% CI, 1.944–2.102). Compared with Uygur, Han, Kazakh, Hui and Mongolian had an increased risk of MCC, which was (OR, 1.075; 95% CI, 1.040–1.111), (OR, 1.414; 95% CI, 1.332–1.501), (OR, 1.515; 95% CI, 1.396–1.644), (OR, 1.566; 95% CI, 1.216–2.017), respectively. Conclusions: There are ethnic and geographic variations in multiple chronic conditions among community-dwelling older people in Xinjiang. The older adults living in northern and southern Xinjiang and Han, Kazakh, Mongolian and Hui older adults have a higher risk of MCC.


  • Open Access

    Plasma tumor necrosis factor-α is associated with sarcopenia in elderly individuals residing in agricultural and pastoral areas of Xinjiang, China

    by Aishanjiang Wumaer, Zhuoya Maimaitiwusiman, Wenwen Xiao, Saiyare Xuekelati, Jinling Liu, Tajiguli Musha, Hongmei Wang

    Background: Inflammatory reactions play a significant role in the occurrence and development of sarcopenia. Determining the association between specific cytokines and sarcopenia may reveal the disease’s pathophysiological mechanism(s). Accordingly, the present study aimed to investigate the association between sarcopenia and inflammatory cytokines among the elderly natural population in agricultural and pastoral areas of Xinjiang.Methods: We conducted a cross-sectional epidemiological survey of the community-dwelling older people using a multi-stage random sampling method in Mulei County in northern Xinjiang and Luopu County in southern Xinjiang from September 2017 to May 2018. Of the 2,100 participants, the statistical analyses included 1,838 participants with complete data. Comparisons of living habits, disease status, biochemical indexes, and levels of interleukin (IL)-4, IL-6, IL-8, IL-10, and tumor necrosis factor (TNF)-α in sarcopenia and non-sarcopenia participants were made in this study.Results: Our study revealed no significant differences (i.e., P > 0.05) in sex, age, ethnicity, smoking and drinking habits, serum renal function, total cholesterol, and diabetes in the elderly between the sarcopenia and non-sarcopenia groups in Xinjiang. However, triglyceride levels (P = 0.004), hypertension (P = 0.019), and abdominal obesity (P < 0.001) in the sarcopenia group were significantly higher than those in the non-sarcopenia group. Moreover, the levels of IL-10 (P < 0.001), IL-4 (P < 0.001), and TNF-α (P < 0.001) in the sarcopenia group were higher than those in the non-sarcopenia group after adjusting for sex, age, hypertension, blood lipid concentration, and obesity. Furthermore, after adjusting for sex, age, hypertension, obesity, and IL-10, IL-4, and IL-6 levels, an increased TNF-α level was also significantly associated with sarcopenia.Conclusion: The results of the present study suggest that an increased plasma level of TNF-α is significantly associated with sarcopenia among elderly individuals residing in Xinjiang’s agricultural and pastoral areas. Further study is still needed to determine the physiological role of “immune aging” in the pathogenesis of sarcopenia.